v3.25.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Commercialization revenue $ 128,940 $ 7,886
License and collaboration revenue 0 687
Total revenue 128,940 8,573
Costs and operating expenses:    
Cost of commercialization revenue 21,009 8,886
Research and development expenses 151,483 224,785
General and administrative expenses 39,886 50,908
Total costs and operating expenses 212,378 284,579
Loss from operations (83,438) (276,006)
Other income (expense), net:    
Interest income 2,110 5,426
Interest expense (4,615) (5,285)
Other income (expense), net: 528 (246)
Total other income (expense), net (1,977) (105)
Loss before provision for (benefit from) income taxes (85,415) (276,111)
Provision for (benefit from) income taxes (12) 15
Net loss (85,403) (276,126)
Other comprehensive gain (loss):    
Unrealized gain (loss) on available-for-sale securities 212 1,863
Comprehensive loss $ (85,191) $ (274,263)
Net loss per common share:    
Basic net loss per common share $ (11.41) $ (65.19)
Diluted net loss per common share $ (11.41) $ (65.19)
Basic weighted-average shares outstanding 7,488 4,236
Diluted weighted-average shares outstanding 7,488 4,236

Source